In a boost to its European advisory business, on Tuesday afternoon investment bank Lazard said it hired Alexis de Rosnay (pictured) as a vice chairman of Lazard International and as a senior member of the firm's global
financial advisory team, effective Nov. 12. De Rosnay, based in London, was most
recently with Lehman Brothers Holdings Inc., where he was co-head of investment banking for Europe and the Middle
East, and was global co-head of healthcare investment banking.
Continue reading below
De Rosnay, 41, joined Lehman Brothers in 2004 and became head of global
healthcare banking last year. Earlier, he served as head of European
healthcare as well as other positions at J.P. Morgan Chase & Co. He
began his investment banking career in 1990 at Rothschild Inc. in Paris
and London. At Lazard, he'll focus on healthcare and large-cap,
European and cross-border transactions.
Georges Ralli, chief
executive of Lazard
European Investment Banking; Kenneth Jacobs, head of Lazard North
America; and William Rucker, CEO of Lazard London and deputy CEO of
Lazard's European Investment Banking business, all praised de Rosnay as
an expert healthcare banker.
Rightfully so. Here are some deals de Rosnay has advised on:
- Teva Pharmaceutical Industries Ltd. on the acquisition of Barr Pharmaceuticals Inc.,
- Aventis SA on its
sale of HR Vet,
- Dako Denmark A/S on its sale to EQT,
- Novartis AG on its acquisition of NeuTec,
- Celltech on its sale to
UCB SA and
- the merger of Hoechst AG and Rhone-Poulenc SA.
De Rosnay is the latest high-profile Lehman banker to leave in a
long line of moves.
Separately,
Lazard also announced that George Bilicic rejoined the firm as chairman
of the power, utilities and infrastructure sector and as a senior
member of the
firm's North American financial advisory business. Bilicic, 45, rejoins
Lazard from leveraged buyout firm Kohlberg Kravis Roberts & Co.,
where he was a managing director and head of infrastructure.
Bilicic originally joined Lazard as a managing director in 2002.
Previously, he was a managing director at Merrill Lynch & Co. and a partner at
New York law firm Cravath, Swaine & Moore LLP, which he joined as
an associate in 1989. -
Baz Hiralal(Bruce Wasserstein, chairman and CEO of Lazard, is the chairman of The Deal LLC.)
